Carlos Cedeno

发表

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

Daniel T. Fisher, P. Wallace, I. Puzanov, 2022, Frontiers in Oncology.

Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

Cheryl L. Allen, P. Wallace, I. Puzanov, 2020, Clinical Cancer Research.